New Ultrasound-Guided scope may slash deadly bleeding risk in liver cancer patients

NCT ID NCT05629845

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a newer, ultrasound-guided endoscopic technique to prevent repeat bleeding from enlarged veins in the stomach or esophagus of liver cancer patients. About 84 adults who recently had such bleeding controlled by standard endoscopy will be randomly assigned to receive either the standard or the ultrasound-guided treatment. The goal is to see which method better reduces the chance of bleeding again within 90 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal varices esophageal varices with bleeding hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Prince of Wales Hospital, The Chinese University of Hong Kong

    RECRUITING

    Shatin, New Territories, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact